Title: Biblio RTF Export
Author: Biblio 7.x

Wollish AC, Ferris MT, Blevins LK, Loo Y-M, Gale M, Heise MT. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology. 2013  ;435(2):269-80.

Ma DY, Suthar MS, Kasahara S, Gale M, Clark EA. CD22 is required for protection against West Nile virus Infection. J Virol. 2013  ;87(6):3361-75.

Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Diamond MS. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013  ;19(4):458-64.

Kumar M, Roe K, Orillo B, Muruve DA, Nerurkar VR, Gale M, Verma S. Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis. J Virol. 2013  ;87(7):3655-67.

Mateo R, Nagamine CM, Spagnolo J, Méndez E, Rahe M, Gale M, Yuan J, Kirkegaard K. Inhibition of cellular autophagy deranges dengue virion maturation. J Virol. 2013  ;87(3):1312-21.

Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013  ;9(1):e1003118.

Horner SM, Gale M. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med. 2013  ;19(7):879-88.

Ermler ME, Yerukhim E, Schriewer J, Schattgen S, Traylor Z, Wespiser AR, Caffrey DR, Chen ZJ, King CH, Gale M, et al. RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge. J Virol. 2013  ;87(9):4846-60.

Ireton RC, Gale M. Systems biology analyses to define host responses to HCV infection and therapy. Curr Top Microbiol Immunol. 2013  ;363:143-67.

Suthar MS, Brassil MM, Blahnik G, McMillan A, Ramos HJ, Proll SC, Belisle SE, Katze MG, Gale M. A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog. 2013  ;9(2):e1003168.

Suthar MS, Diamond MS, Gale M. West Nile virus infection and immunity. Nat Rev Microbiol. 2013  ;11(2):115-28.

Szretter KJ, Daniels BP, Cho H, Gainey MD, Yokoyama WM, Gale M, Virgin HW, Klein RS, Sen GC, Diamond MS. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog. 2012  ;8(5):e1002698.

Gall A, Treuting P, Elkon KB, Loo Y-M, Gale M, Barber GN, Stetson DB. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity. 2012  ;36(1):120-31.

Diamond MS, Gale M. Cell-intrinsic innate immune control of West Nile virus infection. Trends Immunol. 2012  ;33(10):522-30.

Patel MR, Loo Y-M, Horner SM, Gale M, Malik HS. Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol. 2012  ;10(3):e1001282.

Benecke A, Gale M, Katze MG. Dynamics of innate immunity are key to chronic immune activation in AIDS. Curr Opin HIV AIDS. 2012  ;7(1):79-85.

Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, Brassil MM, Sodhi K, Treuting PM, Busch MP, Norris PJ, et al. IL-1? signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012  ;8(11):e1003039.

Suthar MS, Brassil MM, Blahnik G, Gale M. Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar. J Virol. 2012  ;86(14):7704-9.

Rudd PA, Wilson J, Gardner J, Larcher T, Babarit C, Le TT, Anraku I, Kumagai Y, Loo Y-M, Gale M, et al. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J Virol. 2012  ;86(18):9888-98.

Malur M, Gale M, Krug RM. LGP2 downregulates interferon production during infection with seasonal human influenza A viruses that activate interferon regulatory factor 3. J Virol. 2012  ;86(19):10733-8.

Suthar MS, Ramos HJ, Brassil MM, Netland J, Chappell CP, Blahnik G, McMillan A, Diamond MS, Clark EA, Bevan MJ, et al. The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. Immunity. 2012  ;37(2):235-48.

Polyak SJ, Morishima C, Scott JD, Gastaminza P, Cox A, de Araújo EStanislau, Higgs MR, Loo Y-M, Golden-Mason L, Lindenbach BD, et al. A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology. 2012  ;142(1):e1-5.

Lee H-C, Headley MB, Loo Y-M, Berlin A, Gale M, Debley JS, Lukacs NW, Ziegler SF. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol. 2012  ;130(5):1187-1196.e5.

Schnell G, Loo Y-M, Marcotrigiano J, Gale M. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I. PLoS Pathog. 2012  ;8(8):e1002839.

Lazear HM, Pinto AK, Vogt MR, Gale M, Diamond MS. Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol. 2011  ;85(14):7186-94.

Luke JM, Simon GG, Söderholm J, Errett JS, J August T, Gale M, Hodgson CP, Williams JA. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. J Virol. 2011  ;85(3):1370-83.

Loo Y-M, Gale M. Immune signaling by RIG-I-like receptors. Immunity. 2011  ;34(5):680-92.

Perwitasari O, Cho H, Diamond MS, Gale M. Inhibitor of ?B kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection. J Biol Chem. 2011  ;286(52):44412-23.

Brien JD, Daffis S, Lazear HM, Cho H, Suthar MS, Gale M, Diamond MS. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection. PLoS Pathog. 2011  ;7(9):e1002230.

Giordano D, Li C, Suthar MS, Draves KE, Ma DY, Gale M, Clark EA. Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses. J Leukoc Biol. 2011  ;89(3):443-55.

Ireton RC, Gale M. RIG-I like receptors in antiviral immunity and therapeutic applications. Viruses. 2011  ;3(6):906-19.

Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin T-Y, Schneller S, Zust R, Dong H, et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature. 2010  ;468(7322):452-6.

Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, Gale M, Diamond MS. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J Virol. 2010  ;84(23):12125-38.

Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja M-K, et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 2010  ;6(2):e1000757.

Wilkins C, Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol. 2010  ;22(1):41-7.

Malathi K, Saito T, Crochet N, Barton DJ, Gale M, Silverman RH. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA. 2010  ;16(11):2108-19.

Suthar MS, Gale M, Owen DM. Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses. Cell Microbiol. 2009  ;11(6):880-8.

Owen DM, Gale M. Fighting the flu with inflammasome signaling. Immunity. 2009  ;30(4):476-8.

Daffis S, Suthar MS, Szretter KJ, Gale M, Diamond MS. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog. 2009  ;5(10):e1000607.

Horner SM, Gale M. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res. 2009  ;29(9):489-98.

DeWitte-Orr SJ, Mehta DR, Collins SE, Suthar MS, Gale M, Mossman KL. Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN. J Immunol. 2009  ;183(10):6545-53.

Daffis S, Suthar MS, Gale M, Diamond MS. Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J Innate Immun. 2009  ;1(5):435-45.

Gale M, Sen GC. Viral evasion of the interferon system. J Interferon Cytokine Res. 2009  ;29(9):475-6.

Saito T, Gale M. Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity. J Exp Med. 2008  ;205(7):1523-7.

Loo Y-M, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008  ;82(1):335-45.

Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol. 2008  ;82(2):609-16.

Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature. 2008  ;454(7203):523-7.

Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M, Diamond MS. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol. 2008  ;82(17):8465-75.

Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, Narita R, Gale M, Inagaki F, Fujita T. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell. 2008  ;29(4):428-40.

Erickson AK, Gale M. Regulation of interferon production and innate antiviral immunity through translational control of IRF-7. Cell Res. 2008  ;18(4):433-5.

Daffis S, Samuel MA, Suthar MS, Gale M, Diamond MS. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 2008  ;82(21):10349-58.

Loo Y-M, Gale M. Unveiling viral enablers. Nat Biotechnol. 2008  ;26(10):1093-4.

Daffis S, Samuel MA, Keller BC, Gale M, Diamond MS. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 2007  ;3(7):e106.

Loo Y-M, Gale M. Influenza: fatal immunity and the 1918 virus. Nature. 2007  ;445(7125):267-8.

Mibayashi M, Martinez-Sobrido L, Loo Y-M, Cárdenas WB, Gale M, García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol. 2007  ;81(2):514-24.

Keller BC, Johnson CL, Erickson AKaup, Gale M. Innate immune evasion by hepatitis C virus and West Nile virus. Cytokine Growth Factor Rev. 2007  ;18(5-6):535-44.

Saito T, Gale M. Principles of intracellular viral recognition. Curr Opin Immunol. 2007  ;19(1):17-23.

Malathi K, Dong B, Gale M, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature. 2007  ;448(7155):816-9.

Johnson CL, Gale M. CARD games between virus and host get a new player. Trends Immunol. 2006  ;27(1):1-4.

Cárdenas WB, Loo Y-M, Gale M, Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EOllmann, Basler CF. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol. 2006  ;80(11):5168-78.

Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BRG, Silverman RH, Gale M, Diamond MS. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol. 2006  ;80(14):7009-19.

Chien Y, Kim S, Bumeister R, Loo Y-M, Kwon SWon, Johnson CL, Balakireva MG, Romeo Y, Kopelovich L, Gale M, et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell. 2006  ;127(1):157-70.

Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol. 2006  ;80(19):9424-34.

Fredericksen BL, Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol. 2006  ;80(6):2913-23.

Li K, Chen Z, Kato N, Gale M, Lemon SM. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005  ;280(17):16739-47.

Gale M, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature. 2005  ;436(7053):939-45.

Giménez-Barcons M, Wang C, Chen M, Sánchez-Tapias J-M, Sáiz J-C, Gale M. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation. J Interferon Cytokine Res. 2005  ;25(3):152-64.

Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo Y-M, Gale M, Akira S, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 2005  ;175(5):2851-8.

Fredericksen BL, Smith M, Katze MG, Shi P-Y, Gale M. The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol. 2004  ;78(14):7737-47.

Tan S-L, He Y, Huang Y, Gale M. Strategies for hepatitis C therapeutic intervention: now and next. Curr Opin Pharmacol. 2004  ;4(5):465-70.

Gale M, Blakely CM, Darveau A, Romano PR, Korth MJ, Katze MG. P52rIPK regulates the molecular cochaperone P58IPK to mediate control of the RNA-dependent protein kinase in response to cytoplasmic stress. Biochemistry. 2002  ;41(39):11878-87.

Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002  ;2(9):675-87.